These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2518804)

  • 21. Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA.
    Shiomi S; Kuroki T; Kuriyama M; Takeda T; Nishiguchi S; Nakajima S; Tanaka T; Ochi H
    J Nucl Med; 1997 Jan; 38(1):79-82. PubMed ID: 8998156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arterial ketone body ratio as a possible indicator for liver transplantation in fulminant hepatic failure.
    Saibara T; Onishi S; Sone J; Yamamoto N; Shimahara Y; Mori K; Ozawa K; Yamamoto Y
    Transplantation; 1991 Apr; 51(4):782-6. PubMed ID: 2014530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological markers in fulminant hepatitis B.
    Gimson AE; Tedder RS; White YS; Eddleston AL; Williams R
    Gut; 1983 Jul; 24(7):615-7. PubMed ID: 6862284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of serum-soluble CD154 in fulminant hepatic failure.
    Zheng YB; Gao ZL; Zhong F; Huang YS; Peng L; Lin BL; Chong YT
    J Int Med Res; 2008; 36(4):728-33. PubMed ID: 18652769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Admission levels of serum Gc-globulin: predictive value in fulminant hepatic failure.
    Schiødt FV; Bondesen S; Petersen I; Dalhoff K; Ott P; Tygstrup N
    Hepatology; 1996 Apr; 23(4):713-8. PubMed ID: 8666322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis G virus infection in fulminant hepatic failure.
    Sáiz JC; Sans M; Mas A; Olmedo E; Forns X; López-Labrador FX; Restrepo JC; Costa J; Salmerón JM; Guilera M; Ampurdanés S; Sánchez-Tapias JM; Jiménez de Anta MT; Rodés J
    Gut; 1997 Nov; 41(5):696-9. PubMed ID: 9414981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of prognosis in fulminant hepatic failure.
    Tygstrup N; Ranek L
    Semin Liver Dis; 1986 May; 6(2):129-37. PubMed ID: 3749932
    [No Abstract]   [Full Text] [Related]  

  • 28. Urinary and serum zinc levels in chronic pancreatitis.
    Kondo T; Hayakawa T; Shibata T; Kitagawa M; Sakai Y; Ono H
    Pancreas; 1989; 4(1):79-82. PubMed ID: 2717604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history and risk factors in fulminant hepatic failure.
    Poddar U; Thapa BR; Prasad A; Sharma AK; Singh K
    Arch Dis Child; 2002 Jul; 87(1):54-6. PubMed ID: 12089125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically important immunological processes in acute and fulminant hepatitis, mainly due to hepatitis B virus.
    Mackenjee MK; Kiepiela P; Cooper R; Coovadia HM
    Arch Dis Child; 1982 Apr; 57(4):277-82. PubMed ID: 7082040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure.
    Mason A; Sallie R; Perrillo R; Rayner A; Xu L; Dohner DE; Dehner M; Naoumov N; Gelb L; Saha B; O'Grady J; Williams R
    Hepatology; 1996 Dec; 24(6):1361-5. PubMed ID: 8938162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation in the management of fulminant hepatic failure.
    Emond JC; Aran PP; Whitington PF; Broelsch CE; Baker AL
    Gastroenterology; 1989 Jun; 96(6):1583-8. PubMed ID: 2653944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis.
    Dhiman RK; Seth AK; Jain S; Chawla YK; Dilawari JB
    Dig Dis Sci; 1998 Jun; 43(6):1311-6. PubMed ID: 9635624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure.
    Tsai MH; Chen YC; Wu CS; Ho YP; Fang JT; Lien JM; Yang C; Chu YY; Liu NJ; Lin CH; Chiu CT; Chen PC
    Int J Clin Pract; 2005 Nov; 59(11):1289-94. PubMed ID: 16236082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
    Lee WS; McKiernan P; Kelly DA
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):575-81. PubMed ID: 15861019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher serum methionine levels as a predictive factor in patients with irreversible fulminant hepatic failure.
    Sato K; Fukushima D; Doi H; Satomi S
    Transplant Proc; 2013 Jun; 45(5):1904-6. PubMed ID: 23769068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aetiology of icteric hepatitis and fulminant hepatic failure in children and the possible predisposition to hepatic failure by sickle cell disease.
    Yohannan MD; Arif M; Ramia S
    Acta Paediatr Scand; 1990 Feb; 79(2):201-5. PubMed ID: 2157327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure.
    Chung PY; Sitrin MD; Te HS
    Liver Transpl; 2003 Mar; 9(3):248-53. PubMed ID: 12619021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic expression and serum levels of thrombomodulin reflect the extent of liver injury in rats with fulminant hepatic failure and extensive hepatectomy.
    Miyamoto S; Eguchi S; Sugiyama N; Kawazoe Y; Kamohara Y; Fujioka H; Yanaga K; Furui J; Kanematsu T
    Hepatol Res; 2002 Mar; 22(3):206-213. PubMed ID: 11882417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection.
    de la Mata M; Meager A; Rolando N; Daniels HM; Nouri-Aria KT; Goka AK; Eddleston AL; Alexander GJ; Williams R
    Clin Exp Immunol; 1990 Dec; 82(3):479-84. PubMed ID: 2124956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.